Search International and National Patent Collections

1. (WO2018045228) INTERPRETING GENOMIC RESULTS AND PROVIDING TARGETED TREATMENT OPTIONS IN CANCER PATIENTS

Pub. No.:    WO/2018/045228    International Application No.:    PCT/US2017/049724
Publication Date: Fri Mar 09 00:59:59 CET 2018 International Filing Date: Fri Sep 01 01:59:59 CEST 2017
IPC: G06Q 50/22
G06F 19/18
G06F 19/00
Applicants: INTERMOUNTAIN INVENTION MANAGEMENT, LLC
Inventors: NADAULD, Lincoln, D.
HASLEM, Derrick, S.
Title: INTERPRETING GENOMIC RESULTS AND PROVIDING TARGETED TREATMENT OPTIONS IN CANCER PATIENTS
Abstract:
A method for creating a clinical interpretation and recommendation for treatment of a cancer patient is disclosed. The method may include generating sequence of DNA, RNA, cDNA, or protein obtained from the patient's tumor or cancer cells. Clinically significant genetic variants and variants of unknown clinical significance may be identified and separately categorized. Therapies to treat tumors or cancer cells, which include the observed genetic variant may be identified and prioritized according to a series of criteria. A board of experts in various oncology-related fields, which may include machine learning platforms and algorithms, may review and further prioritize the list of treatments. The board may then provide a clinical interpretation and recommendation for conveyance to a treating healthcare provider. The clinical interpretation and recommendation may further include a proposal for genetic testing relevant to the patient, surgery, or radiation therapy.